SEARCH

SEARCH BY CITATION

References

  • 1
    Yatham LN, Kennedy SH, Schaffer A et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2009. Bipolar Disord. 2009; 11: 225255.
  • 2
    Ng F, Mammen OK, Wilting I et al. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord. 2009; 11: 559595.
  • 3
    Cipriani A, Barbui C, Salanti G et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: A multiple-treatments meta-analysis. Lancet 2011; 378: 13061315.
  • 4
    Cade JF. Lithium salts in the treatment of psychotic excitement. Med. J. Aust. 1949; 2: 349352.
  • 5
    Moncrieff J. Lithium: Evidence reconsidered. Br. J. Psychiatry 1997; 171: 113119.
  • 6
    Smith LA, Cornelius V, Warnock A et al. Pharmacological interventions for acute bipolar mania: A systematic review of randomized placebo-controlled trials. Bipolar Disord. 2007a; 9: 551560.
  • 7
    Yildiz A, Vieta E, Leucht S et al. Efficacy of antimanic treatments: Meta-analysis of randomized, controlled trials. Neuropsychopharmacology 2011; 36: 375389.
  • 8
    Hirschfeld RM, Baker JD, Wozniak P et al. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder. J. Clin. Psychiatry 2003; 64: 841846.
  • 9
    Swann AC, Bowden CL, Calabrese JR et al. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am. J. Psychiatry 1999; 156: 12641266.
  • 10
    Ehret MJ, Levin GM. Long-term use of atypical antipsychotics in bipolar disorder. Pharmacotherapy 2006; 26: 11341147.
  • 11
    Lempérière T. Brief history of the development of valproate in bipolar disorders. Encephale 2001; 27: 365372.
  • 12
    Allen MH, Hirschfeld RM, Wozniak PJ et al. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania. Am. J. Psychiatry 2006; 163: 272275.
  • 13
    Okuma T. A history of investigation on the mood-stabilizing effect of carbamazepine in Japan. Seishin Shinkeigaku Zasshi 2002; 104: 647655.
  • 14
    Katagiri H, Takita Y, Tohen M et al. Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: A randomized, double-blind, placebo- and haloperidol-controlled study. J. Affect. Disord. 2012; 136: 476484.
  • 15
    Kanba S, Kawasaki H, Ishigooka J et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (The AMAZE Study). World J. Biol. Psychiatry 2012; (in press).
  • 16
    Thase ME, Jonas A, Khan A et al. Aripiprazole monotherapy in non-psychotic bipolar I depression: Results of 2 randomized, placebo-controlled studies. J. Clin. Psychopharmacol. 2008; 28: 1320.
  • 17
    Smith LA, Cornelius V, Warnock A et al. Acute bipolar mania: A systematic review and meta-analysis of co-therapy vs. monotherapy. Acta Psychiatr. Scand. 2007b; 115: 1220.
  • 18
    Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania. Arch. Gen. Psychiatry 2007; 64: 442445.
  • 19
    Loo C, Katalinic N, Mitchell PB et al. Physical treatments for bipolar disorder: A review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques. J. Affect. Disord. 2011; 132: 113.
  • 20
    Calabrese JR, Keck PE Jr, Macfadden W et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am. J. Psychiatry 2005; 162: 13511360.
  • 21
    Thase ME, Macfadden W, Weisler RH et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: A double-blind, placebo-controlled study (the BOLDER II study). J. Clin. Psychopharmacol. 2006; 26: 600609.
  • 22
    Young AH, McElroy SL, Bauer M et al. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J. Clin. Psychiatry 2010; 71: 150162.
  • 23
    Zornberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: New directions for research. J. Clin. Psychopharmacol. 1993; 13: 397408.
  • 24
    Tohen M, Vieta E, Calabrese J et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch. Gen. Psychiatry 2003; 60: 10791088.
  • 25
    Calabrese JR, Bowden CL, Sachs GS et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J. Clin. Psychiatry 1999; 60: 7988.
  • 26
    Calabrese JR, Huffman RF, White RL et al. Lamotrigine in the acute treatment of bipolar depression: Results of five double-blind, placebo controlled clinical trials. Bipolar Disord. 2008; 10: 323333.
  • 27
    Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: Independent meta-analysis and metaregression of individual patient data from five randomised trials. Br. J. Psychiatry 2009; 194: 49.
  • 28
    Van Lieshout RJ, MacQueen GM. Efficacy and acceptability of mood stabilizers in the treatment of acute bipolar depression: Systematic review. Br. J. Psychiatry 2010; 196: 266273.
  • 29
    Zhang ZJ, Kang WH, Tan QR et al. Adjunctive herbal medicine with carbamazepine for bipolar disorders: A double-blind, randomized, placebo-controlled study. J. Psychiatr. Res. 2007; 41: 360369.
  • 30
    Smith LA, Cornelius VR, Azorin JM et al. Valproate for the treatment of acute bipolar depression: Systematic review and meta-analysis. J. Affect. Disord. 2010; 122: 19.
  • 31
    Kazuo Y, Shigenobu K. Guideline for drug treatment for the acute stage of bipolar depression based on evidences. Jpn. J. Clin. Psychiatry 2008; 37: 397404 (in Japanese).
  • 32
    Amsterdam JD, Shults J. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: A randomized, double-blind, placebo-substitution study. Am. J. Psychiatry 2010; 167: 792800.
  • 33
    Amsterdam JD, Shults J. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: A randomized open-label study. J. Clin. Psychopharmacol. 2008; 28: 171181.
  • 34
    Sachs GS, Nierenberg AA, Calabrese JR et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N. Engl. J. Med. 2007; 356: 17111722.
  • 35
    Van der Loos ML, Mulder PG, Hartong EG et al. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: A multicenter, double-blind, placebo-controlled trial. J. Clin. Psychiatry 2009; 70: 223231.
  • 36
    Daly JJ, Prudic J, Devanand DP et al. ECT in bipolar and unipolar depression: Differences in speed of response. Bipolar Disord. 2001; 3: 95104.
  • 37
    Tohen M, Waternaux CM, Tsuang MT. Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch. Gen. Psychiatry 1990; 47: 11061111.
  • 38
    Schou M. The effect of prophylactic lithium treatment on mortality and suicidal behavior: A review for clinicians. J. Affect. Disord. 1998; 50: 253259.
  • 39
    Weisler RH, Nolen WA, Neijber A et al. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (trial 144: A randomized controlled study). J. Clin. Psychiatry 2011; 72: 14521464.
  • 40
    Goodwin GM, Bowden CL, Calabrese JR et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J. Clin. Psychiatry 2004; 65: 432441.
  • 41
    Tohen M, Calabrese JR, Sachs GS et al. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am. J. Psychiatry 2006; 163: 247256.
  • 42
    McIntyre RS. Aripiprazole for the maintenance treatment of bipolar I disorder: A review. Clin. Ther. 2010; 32 (Suppl. 1): S32S38.
  • 43
    Geddes JR, Burgess S, Hawton K et al. Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. Am. J. Psychiatry 2004; 161: 217222.
  • 44
    Smith LA, Cornelius V, Warnock A et al. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: A systematic review of randomized controlled trials. Bipolar Disord. 2007; 9: 394412.
  • 45
    Bowden CL, Calabrese JR, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatry 2003; 60: 392400.
  • 46
    Calabrese JR, Bowden CL, Sachs G et al. for the Lamictal 605 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J. Clin. Psychiatry 2003; 64: 10131024.
  • 47
    Geddes JR, Goodwin GM, Rendell J et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised open-label trial. Lancet 2010; 375: 385395.
  • 48
    Cipriani A, Pretty H, Hawton K et al. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials. Am. J. Psychiatry 2005; 162: 18051819.
  • 49
    Koyama T, Higuchi T, Yamawaki S et al. Clinical evaluation of Lamotrigine for bipolar I disorder – Placebo control double blind comparative study with inhibition of the recurrence of mood episodes as an index. Jpn. J. Clin. Psychiatry 2011; 40: 9383 (in Japanese).
  • 50
    Van der Loos ML, Mulder P, Hartong EG et al. for the LamLit Study Group: Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: A randomized, placebo-controlled trial with a novel design. Bipolar Disord. 2011; 13: 111117.
  • 51
    Bowden CL, Calabrese JR, McElroy SL et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch. Gen. Psychiatry 2000; 57: 481489.
  • 52
    Okuma T, Inanaga K, Otsuki S et al. A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology (Berl) 1981; 73: 9596.
  • 53
    Ceron-Litvoc D, Soares BG, Geddes J et al. Comparison of carbamazepine and lithium in treatment of bipolar disorder: A systematic review of randomized controlled trials. Hum. Psychopharmacol. 2009; 24: 1928.
  • 54
    Tohen M, Greil W, Calabrese JR et al. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: A 12-month, randomized, double-blind, controlled clinical trial. Am. J. Psychiatry 2005; 162: 12811290.
  • 55
    Suppes T, Vieta E, Liu S et al. Maintenance treatment for patients with bipolar I disorder: Results from a North American study of quetiapine in combination with lithium or divalproex (trial 127). Am. J. Psychiatry 2009; 166: 476488.
  • 56
    Vieta E, Suppes T, Eggens I et al. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J. Affect. Disord. 2008; 109: 251263.
  • 57
    Macfadden W, Alphs L, Haskins JT et al. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently. Bipolar Disord. 2009; 11: 827839.
  • 58
    Keck PE Jr, Calabrese JR, McIntyre RS et al. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: A 100-week, double-blind study versus placebo. J. Clin. Psychiatry 2007; 68: 14801491.
  • 59
    Marcus R, Khan A, Rollin L et al. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: A multicenter, double-blind, randomized study. Bipolar Disord. 2011; 13: 133144.
  • 60
    Woo YS, Bahk WM, Chung MY et al. Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: A 6-month, randomized, placebo-controlled, double-blind maintenance trial. Hum. Psychopharmacol. 2011; 26: 543553.
  • 61
    Carlson BX, Ketter TA, Sun W et al. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): A randomized, multicenter, double-blind study (CN138-392). Bipolar Disord. 2012; 14: 4153.
  • 62
    Gelenberg AJ et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N. Engl. J. Med. 1989; 321: 14891493.
  • 63
    McKnight RF, Adida M, Budge K et al. Lithium toxicity profile: A systematic review and meta-analysis. Lancet 2012; 379: 721728.
  • 64
    Perry A, Tarrier N, Morriss R et al. Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ 1999; 318: 149153.
  • 65
    Colom F, Vieta E, Martinez-Aran A et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch. Gen. Psychiatry 2003; 60: 402407.
  • 66
    Colom F, Vieta E, Sanchez-Moreno J et al. Psychoeducation for bipolar II disorder: An exploratory, 5-year outcome subanalysis. J. Affect. Disord. 2009; 112: 3035.
  • 67
    Frank E, Kupfer DJ, Thase ME et al. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch. Gen. Psychiatry 2005; 62: 9961004.
  • 68
    Miklowitz DJ, George EL, Richards JA et al. A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch. Gen. Psychiatry 2003; 60: 904912.
  • 69
    Lam DH, Watkins ER, Hayward P et al. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: Outcome of the first year. Arch. Gen. Psychiatry 2003; 60: 145152.
  • 70
    Zaretsky A, Lancee W, Miller C et al. Is cognitive-behavioural therapy more effective than psychoeducation in bipolar disorder? Can. J. Psychiatry 2008; 53: 441448.
  • 71
    Lynch D, Laws KR, McKenna PJ. Cognitive behavioural therapy for major psychiatric disorder: Does it really work? A meta-analytical review of well-controlled trials. Psychol. Med. 2010; 40: 924.
  • 72
    Bauer MS, Mitchner L. What is a ‘mood stabilizer'? An evidence-based response. Am. J. Psychiatry 2004; 161: 318.
  • 73
    Suppes T, Marangell LB, Bernstein IH et al. A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. J. Affect. Disord. 2008; 111: 334343.
  • 74
    Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: Results of the MAP study. Neuropsychobiology 2000; 42 (Suppl. 1): 210.
  • 75
    Suppes T. Is there a role for antidepressants in the treatment of bipolar II depression? Am. J. Psychiatry 2010; 167: 738740.
  • 76
    Calabrese JR, Shelton MD, Rapport DJ et al. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am. J. Psychiatry 2005; 162: 21522161.
  • 77
    Calabrese JR, Suppes T, Bowden CL et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J. Clin. Psychiatry 2000; 61: 841850.
  • 78
    Langosch JM, Drieling T, Biedermann NC et al. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate. J. Clin. Psychopharmacol. 2008; 28: 555560.
  • 79
    Bauer MS, Whybrow PC, Winokur A. Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism. Arch. Gen. Psychiatry 1990a; 47: 427432.
  • 80
    Bauer MS, Whybrow PC. Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: A preliminary study. Arch. Gen. Psychiatry 1990b; 47: 435440.